Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.
2 reports, 2 independent
Updated Sep 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Merck
public company in Indonesia
-
AbbVie
pharmaceutical company